HOW LONG SHOULD THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA CONTINUE? FOCUS ON SHORT-COURSE ANTIMICROBIAL THERAPY

Abstract

Till today, the duration of antibiotic therapy for community-acquired pneumonia (EP) remains a subject of debate. In different clinical guidelines the duration of antibiotic administration varies. Meanwhile, there is growing evidence that short-term antibiotic regimens for non-severe respiratory infections of the lower respiratory tract seem attractive and promising.

Keywords

• community-acquired pneumonia
• antimicrobial therapy
• course duration